Messmer Elisabeth M

Kahook Malik Y, Rapuano Christopher J, Messmer Elisabeth M, Radcliffe Nathan M, Galor Anat, Baudouin Christophe

Preservatives in glaucoma drops, especially BAK, cause ocular surface disease. Reducing/eliminating BAK via preservative-free options or non-pharmacological treatments improves patient quality of life and surgical outcomes.

Messmer Elisabeth M, Baudouin Christophe, Benitez-Del-Castillo José-Manuel, Iester Michele, Anton Alfonso, Thygesen John et al.

Experts developed 24 consensus recommendations for managing ocular surface inflammation in glaucoma patients. Key findings emphasize investigating OSI in all glaucoma patients, minimizing preserved drops, and using a subtractive treatment approach to improve ocular health.

Baudouin Christophe, Kolko Miriam, Melik-Parsadaniantz Stéphane, Messmer Elisabeth M

This review highlights that inflammation is a widespread, dysregulated process throughout the eye in glaucoma, contributing to disease progression and offering potential anti-inflammatory therapeutic targets.

Messmer Elisabeth M, Valet Véronique M, Kampik Anselm

This study found distinct basement membrane zone component differences between normal conjunctiva, skin, and glaucoma conjunctiva, with glaucoma showing increased laminin β1 and γ2. These variations may explain ocular disease susceptibility.